New Jersey-based Catalent Inc. said James Quella retired as a board member after nine years of service.
Concurrently, the pharmaceuticals company added Rosemary Crane, John Greisch and Christa Kreuzburg to its board
Crane serves as a board member for Edge Therapeutics Inc., Teva Pharmaceutical Industries Ltd. and Zealand Pharma A/S. She retired in 2014 from MELA Sciences Inc., where she served as president and CEO.
Greisch is set to retire later in 2018 as the president and CEO of Hill-Rom Holdings Inc.
Kreuzburg has been a consultant in the healthcare sector after retiring from Bayer AG in 2009. She is a board member of Tecan Trading AG.